Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Also known as: Stage 4 Paranasal Sinus and Nasal Cavity Squamous Cell Carcinoma / Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01933 | 7-Hydroxystaurosporine | 1 | Completed | 1 |
| DB12442 | Alvespimycin | 1 | Completed | 1 |
| DB00112 | Bevacizumab | 1 | Completed | 1 |
| DB00958 | Carboplatin | 1 | Terminated | 1 |
| DB00002 | Cetuximab | 1 | Completed | 1 |
| DB00002 | Cetuximab | 1 | Terminated | 1 |
| DB00530 | Erlotinib | 1 | Completed | 2 |
| DB00099 | Filgrastim | 1 | Completed | 1 |
| DB00544 | Fluorouracil | 1 | Completed | 1 |
| DB01005 | Hydroxyurea | 1 | Completed | 1 |
| DB00762 | Irinotecan | 1 | Completed | 1 |
| DB01229 | Paclitaxel | 1 | Terminated | 1 |
| DB01268 | Sunitinib | 1 | Terminated | 1 |
| DB02546 | Vorinostat | 1 | Terminated | 1 |
| DB00112 | Bevacizumab | 1 / 2 | Completed | 2 |
| DB00002 | Cetuximab | 1 / 2 | Completed | 1 |
| DB01248 | Docetaxel | 1 / 2 | Completed | 1 |
| DB00530 | Erlotinib | 1 / 2 | Completed | 3 |
| DB00112 | Bevacizumab | 2 | Completed | 1 |
| DB01101 | Capecitabine | 2 | Completed | 1 |
| DB00958 | Carboplatin | 2 | Completed | 1 |
| DB04849 | Cediranib | 2 | Completed | 1 |
| DB00002 | Cetuximab | 2 | Completed | 2 |
| DB00515 | Cisplatin | 2 | Terminated | 1 |
| DB00530 | Erlotinib | 2 | Completed | 1 |
| DB11680 | Ficlatuzumab | 2 | Completed | 1 |
| DB01259 | Lapatinib | 2 | Completed | 2 |
| DB01229 | Paclitaxel | 2 | Completed | 1 |
| DB01268 | Sunitinib | 2 | Completed | 1 |